JP2014533282A5 - - Google Patents

Download PDF

Info

Publication number
JP2014533282A5
JP2014533282A5 JP2014541358A JP2014541358A JP2014533282A5 JP 2014533282 A5 JP2014533282 A5 JP 2014533282A5 JP 2014541358 A JP2014541358 A JP 2014541358A JP 2014541358 A JP2014541358 A JP 2014541358A JP 2014533282 A5 JP2014533282 A5 JP 2014533282A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
urea
dioxoimidazolidin
bromophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014541358A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014533282A (ja
JP6078075B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/064571 external-priority patent/WO2013071203A1/en
Publication of JP2014533282A publication Critical patent/JP2014533282A/ja
Publication of JP2014533282A5 publication Critical patent/JP2014533282A5/ja
Application granted granted Critical
Publication of JP6078075B2 publication Critical patent/JP6078075B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014541358A 2011-11-10 2012-11-10 ホルミルペプチド受容体様1(fprl−1)受容体調節因子としての2,5−ジオキソイミダゾリジン−1−イル−3−フェニル尿素誘導体 Expired - Fee Related JP6078075B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161558080P 2011-11-10 2011-11-10
US61/558,080 2011-11-10
PCT/US2012/064571 WO2013071203A1 (en) 2011-11-10 2012-11-10 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017004062A Division JP6392382B2 (ja) 2011-11-10 2017-01-13 ホルミルペプチド受容体様1(fprl−1)受容体調節因子としての2,5−ジオキソイミダゾリジン−1−イル−3−フェニル尿素誘導体

Publications (3)

Publication Number Publication Date
JP2014533282A JP2014533282A (ja) 2014-12-11
JP2014533282A5 true JP2014533282A5 (cg-RX-API-DMAC7.html) 2017-01-05
JP6078075B2 JP6078075B2 (ja) 2017-02-08

Family

ID=47222328

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014541358A Expired - Fee Related JP6078075B2 (ja) 2011-11-10 2012-11-10 ホルミルペプチド受容体様1(fprl−1)受容体調節因子としての2,5−ジオキソイミダゾリジン−1−イル−3−フェニル尿素誘導体
JP2017004062A Expired - Fee Related JP6392382B2 (ja) 2011-11-10 2017-01-13 ホルミルペプチド受容体様1(fprl−1)受容体調節因子としての2,5−ジオキソイミダゾリジン−1−イル−3−フェニル尿素誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017004062A Expired - Fee Related JP6392382B2 (ja) 2011-11-10 2017-01-13 ホルミルペプチド受容体様1(fprl−1)受容体調節因子としての2,5−ジオキソイミダゾリジン−1−イル−3−フェニル尿素誘導体

Country Status (13)

Country Link
US (1) US8492556B2 (cg-RX-API-DMAC7.html)
EP (2) EP3103797B1 (cg-RX-API-DMAC7.html)
JP (2) JP6078075B2 (cg-RX-API-DMAC7.html)
KR (1) KR102271500B1 (cg-RX-API-DMAC7.html)
CN (1) CN104114541A (cg-RX-API-DMAC7.html)
AU (2) AU2012335039C1 (cg-RX-API-DMAC7.html)
BR (1) BR112014011316A2 (cg-RX-API-DMAC7.html)
CA (1) CA2855390C (cg-RX-API-DMAC7.html)
DK (1) DK3103797T3 (cg-RX-API-DMAC7.html)
ES (1) ES2733826T3 (cg-RX-API-DMAC7.html)
RU (1) RU2645673C2 (cg-RX-API-DMAC7.html)
TR (1) TR201909663T4 (cg-RX-API-DMAC7.html)
WO (1) WO2013071203A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX376348B (es) 2011-10-26 2025-03-07 Allergan Inc Derivados de amida de aminoacidos sustituidos con n-urea como moduladores de receptor de tipo peptido receptor de formilo-1 (fprl-1).
US8492556B2 (en) * 2011-11-10 2013-07-23 Allergan, Inc. 2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators
US9850264B2 (en) * 2013-03-06 2017-12-26 Allergan, Inc. Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
KR20210024691A (ko) 2013-03-06 2021-03-05 알러간, 인코포레이티드 피부 질환 치료용 포르밀 펩티드 수용체 2의 항진제의 용도
AR097279A1 (es) * 2013-08-09 2016-03-02 Actelion Pharmaceuticals Ltd Derivados de benzimidazolil-metil urea como agonistas del receptor de alx
RU2703725C1 (ru) 2013-11-21 2019-10-22 Аллерган, Инк. Производные фенилкарбамата в качестве модуляторов формилпептидного рецептора
PE20161206A1 (es) * 2013-11-28 2016-11-05 Kyorin Seiyaku Kk Derivado de urea o sal farmacologicamente aceptable del mismo
WO2015116566A1 (en) 2014-01-29 2015-08-06 Allergan, Inc. 2,5-dioxoimidazolidin-1-yl-3-urea derivatives as formyl peptide modulators
US9604934B2 (en) 2014-01-29 2017-03-28 Allergan, Inc. Urea hydantoin derivatives as formyl peptide modulators
EP3145916B1 (en) * 2014-05-21 2020-02-12 Allergan, Inc. Imidazole derivatives as formyl peptide receptor modulators
AU2015360291A1 (en) 2014-12-11 2017-07-13 President And Fellows Of Harvard College Inhibitors of cellular necrosis and related methods
EA201792382A1 (ru) * 2015-05-27 2018-04-30 Киорин Фармасютикал Ко., Лтд. Производное мочевины или его фармакологически приемлемая соль
US10858314B2 (en) 2015-05-27 2020-12-08 Kyorin Pharmaceutical Co., Ltd. Urea derivative or pharmacologically acceptable salt thereof
JP2020015664A (ja) * 2016-11-21 2020-01-30 宇部興産株式会社 含窒素多環式ヘテロ環誘導体
WO2018227067A1 (en) * 2017-06-09 2018-12-13 Bristol-Myers Squibb Company Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists
MY204384A (en) * 2018-03-05 2024-08-27 Bristol Myers Squibb Co Phenylpyrrolidinone formyl peptide 2 receptor agonists
KR102217512B1 (ko) * 2020-07-07 2021-02-19 한화시스템 주식회사 배터리 관리 시스템을 통한 회수 요청 또는 자동 복귀를 수행하는 무인 잠수정
CN114805334B (zh) * 2022-05-24 2023-06-09 深圳大学 一种QC和GSK-3β多靶向抑制剂及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3924531B2 (ja) * 2000-05-31 2007-06-06 田辺製薬株式会社 αLβ2介在細胞接着阻害剤
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
WO2003006424A1 (en) * 2001-07-10 2003-01-23 4Sc Ag Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
FR2850652B1 (fr) * 2003-01-31 2008-05-30 Aventis Pharma Sa Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
CN1894580A (zh) * 2003-11-07 2007-01-10 阿卡蒂亚药品公司 脂氧素受体fprl1作为一种用于鉴定能有效治疗疼痛和炎症化合物的工具
US20090253908A1 (en) * 2004-03-11 2009-10-08 Glaxo Group Limited Novel m3 muscarinic acetylchoine receptor antagonists
CN100506802C (zh) * 2004-06-04 2009-07-01 中国科学院上海药物研究所 一类甲酰肽样受体-1调节剂、其制备方法和用途
US20080004282A1 (en) * 2006-04-10 2008-01-03 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
JP2011503182A (ja) * 2007-11-15 2011-01-27 エーザイ・アール・アンド・ディー・マネジメント株式会社 使用方法
US8492556B2 (en) * 2011-11-10 2013-07-23 Allergan, Inc. 2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators
US8541577B2 (en) * 2011-11-10 2013-09-24 Allergan, Inc. Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators
EP2814815A1 (en) * 2012-02-16 2014-12-24 Allergan, Inc. Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators

Similar Documents

Publication Publication Date Title
JP2014533282A5 (cg-RX-API-DMAC7.html)
RU2014122753A (ru) Производные 2,5-диоксоимидазолидин-1-ил-3-фенилмочевины в качестве модуляторов формилпептидного рецептора 1 (fprl-1)
JP2016512194A5 (cg-RX-API-DMAC7.html)
RU2424233C2 (ru) Производные бензимидазола, методы их получения, применение их в качестве агонистов фарнезоид-х-рецептора (fxr) и содержащие их фармацевтические препараты
Gaba et al. Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions
JP2012525431A5 (cg-RX-API-DMAC7.html)
ME00044B (me) Substituisani imidazoli i njihova upotreba kao pesticida
RU2015136774A (ru) Применение агонистов формилпептидного рецептора 2 для лечения воспалительных заболеваний глаз
RU2015106787A (ru) Замещенные пирролы, активные в качестве ингибиторов киназ
RU2005111225A (ru) Производные триазаспиро[5.5]ундекана и лекарственные средства, содержащие их в качестве активного ингредиента
RU2011121665A (ru) Производные 7-гидроксибензимидазол-4-илметанона и содержащие их ингибиторы рвк
JP2014516360A5 (cg-RX-API-DMAC7.html)
KR20080080410A (ko) 이미다졸린 유도체의 치환된 2-이미다졸의 용도
FI3625233T5 (fi) 3-(((((2s,5r)-2-karbamoyyli-7-okso-1,6-diatsabisyklo[3.2.1]oktan-6-yyli)oksi)sulfonyyli)oksi)-2,2-dimetyylipropanoaattijohdannaisia ja niihin liittyviä yhdisteitä beetalaktamaasiestäjien suun kautta otettavina aihiolääkkeinä bakteeri-infektioiden hoitamiseksi
JP2013507425A5 (cg-RX-API-DMAC7.html)
RU2013151174A (ru) Замещенные пиримидинилпирролы, активные в качестве ингибиторов киназы
RU2014111980A (ru) Сшиваемая композиция, способная к сшиванию по реакции присоединения михаэля (rma)
EA031030B1 (ru) Ингибиторы фактора в комплемента на основе производных пиперидинилиндола и их применение
JP2012507525A5 (cg-RX-API-DMAC7.html)
RU2389722C2 (ru) Варианты имидазола в качестве модуляторов рецептора гамма-аминомасляной кислоты (gaba) для лечения желудочно-кишечных (жк) расстройств
EP1261601A1 (de) Substituierte indole zur modulierung von nfkb-aktivität
RU2503663C2 (ru) Мостиковые шестичленные циклические соединения
JP2010539151A5 (cg-RX-API-DMAC7.html)
JP2015535834A5 (cg-RX-API-DMAC7.html)
WO2012109491A1 (en) Methods and compositions for improving cognitive function